Multimodal Fusion for Biomedical Data

• Multimodal fusion is the integration of diverse biomedical data types using principled machine learning to enhance prediction and clinical decision-making.
• Key challenges include intra- and inter-modal heterogeneities, missing data, and dimensional imbalances that require adaptive, robust architectures.
• Innovative strategies such as tensor fusion, graph-based models, and frequency-domain harmonization have demonstrated measurable improvements in benchmark tasks.

Multimodal fusion for heterogeneous biomedical data refers to algorithmic strategies for integrating diverse data types—such as medical images, omics, clinical records, and sensor data—within principled machine learning frameworks to support inference, prediction, and clinical decision-making. Biomedical data is characterized by profound inter- and intra-modality variability, pervasive sparsity, dimensional and distributional heterogeneity, missingness, and often complex biological correlations. Effective multimodal fusion architectures seek to extract complementary information across modalities while robustly addressing these heterogeneities and real-world data gaps.

1. Foundational Challenges in Heterogeneous Biomedical Fusion

The heterogeneity of biomedical data spans several axes:

• Intra-modal sparsity and heterogeneity: Medical images (e.g., whole-slide images, MRI, CT) may comprise thousands of patches, few of which are prognostic; genomics or transcriptomics features are high-dimensional, with only subsets being disease-relevant. Intrinsic variability arises from staining protocols, acquisition hardware, genetic background, and micro-environmental context (Zhang et al., 27 Mar 2025).
• Inter-modal heterogeneity: Data modalities exhibit fundamentally disparate feature statistics, noise profiles, distributions, and often require specialized preprocessing (e.g., 2D/3D image encoding, graph representations for molecular structure, sequence encoding for EMRs or genomics).
• Missingness and imbalance: Clinical datasets frequently lack entire modalities for subsets of patients or time intervals, necessitating architectures that degrade gracefully and do not rely on pairwise completeness (Zhang et al., 27 Mar 2025, Jiang et al., 19 Sep 2025, Wang et al., 2023).
• Information redundancy and synergy: Not all modalities provide incremental information; joint fusion can be redundant or, in complementary regimes, synergistic, depending on the SNR structure and inter-modality noise correlations (Sameni, 2023, Farhadizadeh et al., 11 May 2025).
• Dimensionality imbalance and limited sample size: Imaging modalities may provide orders of magnitude more features than tabular or sequence data, with small-to-moderate cohort sizes accentuating overfitting risk.

These challenges require fusion frameworks that are modality-adaptive, information-efficient, and mathematically robust to missing data, variable signal-to-noise, and heterogeneity.

2. Taxonomy of Multimodal Fusion Strategies

Fusion methodologies can be systematically categorized:

Fusion Type	Description	Pros	Cons
Early/Feature-level Fusion	Concatenate raw/preprocessed features; single joint encoder (Cui et al., 2022, Farhadizadeh et al., 11 May 2025)	Captures low-level cross-modal synergy	Requires modality alignment; fragile to missing data, dimensional explosion
Intermediate/Joint Fusion	Encode each modality separately; fuse at intermediate layer(s) (e.g., via MLP, attention, tensor fusion) (Zhang et al., 27 Mar 2025, Hemker et al., 2023, Ngo et al., 2 Jun 2025)	Balances modality-specific and cross-modal learning; mitigates imbalance	More complex; susceptible to partial missingness
Late/Decision-level Fusion	Independent models per modality; combine (average, weighted sum, meta-classifier) (Ngo et al., 2 Jun 2025, Holste et al., 2023)	Robust to missing modalities; simple	Ignores feature-level synergy; may underuse information
Hybrid/Hierarchical Fusion	Multi-stage integration at several depths; combines feature and decision-level fusion (Jorf et al., 7 Aug 2025, Cui et al., 2022)	Multi-grained synergy and robustness	High architectural complexity, often compute-demanding
Graph-based/Patient-centric Fusion	Nodes represent patients and modality-specific attributes; graph learning aggregates over multimodal edges (Kim et al., 2022, Jiang et al., 19 Sep 2025)	Captures higher-order relationships, robust to missingness	Requires specialized infrastructure, can be computationally intensive

Advanced approaches such as low-rank tensor fusion, adaptive attention, co-attention, spectral harmonization, or ensemble mutual learning further enrich this taxonomy (Zhang et al., 27 Mar 2025, Hemker et al., 2024, Liang et al., 27 Jul 2025).

3. Architectures and Mathematical Foundations

Recent fusion frameworks address biomedical heterogeneity through architectural innovations:

3.1 Adaptive Expert Architectures

AdaMHF introduces Progressive Residual Expert Expansion (PREE), where, at each layer, modality-specific “experts” (e.g., specialized CNNs for pathology, SNNs for genomics) are adaptively activated on a per-sample basis via gated softmax selection. This mechanism tailors representation learning to intra- and inter-modal heterogeneity, while a residual branch ensures stable transfer learning (Zhang et al., 27 Mar 2025).

3.2 Hierarchical and Token Selection

AdaMHF deploys Adaptive Token Selection and Aggregation (ATSA) to select the most informative tokens from thousands of candidates, pruning non-contributory features and reducing computational load by almost 90% without discarding salient information (Zhang et al., 27 Mar 2025). This combats intra-modal sparsity.

3.3 Tensorial and Low-Rank Fusion

Low-rank multimodal fusion (LMF) leverages Kronecker or Hadamard product decompositions to model high-order cross-modal interactions efficiently (complexity O(r(n_p+n_g))); these operations are widely used in state-of-the-art frameworks (Zhang et al., 27 Mar 2025, Ngo et al., 2 Jun 2025, Wang et al., 2023, Cui et al., 2022, Farhadizadeh et al., 11 May 2025). Factorized fusion reduces parameter count and overfitting risk in small data regimes.

3.4 Graph-based and Disease-Aware Aggregation

HGDC-Fuse constructs a patient-centric heterogeneous graph, integrating asynchronous/incomplete clinical time-series and imaging nodes, with edge types encoding temporal, cross-patient, and cross-modal relations. A disease-correlation-guided attention layer dynamically modulates modality weights per disease, resolving evidentiary inconsistencies (Jiang et al., 19 Sep 2025). Contrasting approaches such as HetMed represent patients as nodes in multiplex graphs spanning multiple clinical feature subspaces (Kim et al., 2022).

3.5 Missing-Modality Mechanisms

Robust handling of missingness is achieved by: (i) confidence-guided multi-stage fusion (Jorf et al., 7 Aug 2025), (ii) simultaneous modality dropout with learnable modality tokens (Gu et al., 22 Sep 2025), (iii) auxiliary masking and missingness modules (Wang et al., 2023), (iv) skip-layer approaches (e.g., HEALNet directly skips missing data branches) (Hemker et al., 2023), and (v) explicitly supervised fusion over all possible modality subsets (Gu et al., 22 Sep 2025).

3.6 Frequency-Domain Harmonization

The Multimodal Lego (MM-Lego) framework harmonizes latent representations from arbitrary encoders by mapping all outputs to a common shape in the frequency (Fourier) domain. This technique ensures phase/magnitude alignment and enables plug-and-play model merging or minimal fine-tuning, avoiding information interference that plagues naive merges (Hemker et al., 2024).

3.7 Attention, Contrastive, and Mutual Learning

Recent advances utilize contrastive learning on paired and fused embeddings (modality-aware NCE losses), attention-gated fusion with self/co/cross-attention, and deep mutual learning among a committee/ensemble of fusion models with flexible mutual information sharing (Meta Fusion) (Zhang et al., 27 Mar 2025, Farhadizadeh et al., 11 May 2025, Liang et al., 27 Jul 2025, Holste et al., 2023).

4. Evaluation Benchmarks and Empirical Results

Fusion methods are benchmarked on heterogeneous datasets with paired and missing modalities, using tasks such as survival prediction, multi-disease diagnosis, DDI prediction, and segmentation:

• Survival prediction (TCGA cohorts): AdaMHF achieved C-index 0.737 vs prior SOTA 0.719, with gains of 1–3.8% in missing-modality regimes; ATSA and PREE modules reduced computation and maintained performance when modalities were dropped (Zhang et al., 27 Mar 2025).
• Multi-disease prediction: HGDC-Fuse outperformed baselines with macro-PRAUC 0.4700 (matched) and improved disease-specific precision by up to 55% for conditions with high modal inconsistency (Jiang et al., 19 Sep 2025).
• Drug-drug interaction (MUDI): Intermediate (joint) fusion surpassed late fusion by 4–8 points in Macro-F1. Molecular structure graphs contributed the strongest single-modality predictive power (Ngo et al., 2 Jun 2025).
• Image-omics fusion: HEALNet (hybrid early-fusion attention) produced up to 7% multimodal uplift in C-index on multi-omics + WSI survival tasks, while maintaining graceful degradation under missing inputs (Hemker et al., 2023).
• Clinical prediction (MIMIC datasets): MedPatch’s confidence-guided, multi-stage pipeline yielded AUROC 0.876 for in-hospital mortality and 0.862 (AUPRC 0.614) for multi-label condition classification, outperforming baselines and being robust to partial modality missingness (Jorf et al., 7 Aug 2025).
• Flexible model merging (MM-Lego): Shape-consistent, frequency-domain harmonized wrappers achieved SOTA in 5/7 datasets without retraining; plug-and-play operation and resilience to unpaired training data were demonstrated (Hemker et al., 2024).

5. Practical Design Considerations and Theoretical Insights

5.1 Information-Theoretic Criteria

Mutual information and Fisher information analyses establish that fusing modalities increases information when noise is independent or complementary, while redundancy can be formally identified and unnecessary channels pruned (Sameni, 2023). CRLB expressions and SNR-matrix eigen-analysis guide sensor selection, fusion benefit, and optimal model design.

5.2 Handling Dimensionality and Sample Size

Regularization via auxiliary supervision, cross-modal reconstruction, orthogonality constraints, and weight sharing attenuate overfitting on high-dimensional, low-sample data typical in biomedical contexts (Holste et al., 2023, Farhadizadeh et al., 11 May 2025). Auxiliary tasks—such as clinical feature prediction from image embeddings—have empirically boosted stability and accuracy (Holste et al., 2023).

5.3 Modality Selection and Interpretability

Feature selection, attention-weighted fusion, and explainable AI methods (CAM, SHAP, gradient saliency, attention heatmaps) enhance the interpretability and practical utility of complex fusion models (Cui et al., 2022, Wenderoth, 2024). Theoretical redundancy/synergy criteria enable rational reduction of modal complexity (Sameni, 2023).

5.4 Missingness/Imbalance Handling

Losses supporting all label-available modality combinations, surrogate tokens for missing modalities, explicit missingness-induced auxiliary heads, and masking during training maintain performance in incomplete records scenarios (Hemker et al., 2023, Gu et al., 22 Sep 2025, Wang et al., 2023, Jorf et al., 7 Aug 2025).

6. Clinical and Research Implications

Multimodal fusion underpins advances in predictive medicine (oncology, neurology, pharmacology), multi-disease screening, and segmentation/localization tasks for intervention planning. Limitations remain in generalizability to new modalities, computational cost (high-order fusion, graph models, attention networks), and comprehensive clinical validation (single-institution bias, limited real-world missingness studies) (Xiang et al., 18 May 2025).

Empirical evidence uniformly confirms that robust multimodal architectures outperform unimodal and naive concatenation approaches, particularly under real-world noise, missing data, and patient variability. The synergy is maximized when fusion design is aligned with the signal structure (heterogeneity, redundancy, sample size), and dynamic/adaptive mechanisms conferred through learnable attention, expert selection, or graph-based aggregation.

7. Emerging Directions and Open Challenges

Promising trajectories include:

• Frequency/harmonic domain harmonization to enable topology-agnostic fusion and modular encoder integration (Hemker et al., 2024).
• Disease or task-guided attention for disease-specific cross-modal weighing and interpretation (Jiang et al., 19 Sep 2025).
• Self-supervised and contrastive objectives that bind unimodal and cross-modal representations for resilience and transferability (Gu et al., 22 Sep 2025).
• Neural architecture search and meta-fusion strategies that adaptively select optimal fusion sites and mechanisms per dataset/task (Farhadizadeh et al., 11 May 2025, Liang et al., 27 Jul 2025).
• Broader clinical deployment: Expansion to new modalities (e.g., waveforms, pathology, longitudinal records), larger multi-center datasets, real-time and on-device implementations (Xiang et al., 18 May 2025).

Challenges persist in systematic evaluation under severe missingness, managing computational and annotation costs, promoting explainability, and developing standardized benchmarks for fair comparison across strategies.

---

The continued evolution of multimodal fusion frameworks for heterogeneous biomedical data is guided by principled mathematical foundations, robust architectures tailored to biomedical context, and empirical benchmarks evidencing measurable uplift in clinically relevant prediction and interpretability. Architecture selection entails careful balancing of synergy, robustness, interpretability, and compute, with adaptive, hierarchical, and information-aware fusion designs marking the current frontier (Zhang et al., 27 Mar 2025, Hemker et al., 2024, Jorf et al., 7 Aug 2025, Sameni, 2023, Hemker et al., 2023, Jiang et al., 19 Sep 2025).